ZURICH, Feb. 27, 2020 /PRNewswire/ -- Neurimmune AG, the discoverer of aducanumab and cinpanemab, announced today enrollment of the first patient in a Phase 1 clinical trial to evaluate NI006 in transthyretin amyloid cardiomyopathy (ATTR cardiomyopathy).

NASHVILLE, Tenn., Feb. 27, 2020 /PRNewswire/ -- Promises Behavioral Health ("Promises"), a growing national provider of comprehensive behavioral health, substance use disorder treatment and related services, today announced that its Chairman, Rob Waggener, will take on the added responsibilities of interim Chief Executive Officer. Mr.

HERTFORDSHIRE, England and PITTSBURGH and NEW YORK, Feb. 27, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced the remaining appointees to the inaugural 13-member Board of Directors for Viatris, the new company that will result from the combination of Mylan and Upjohn,

LEXINGTON, Mass., Feb. 27, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has entered into a common stock purchase agreement (the "Agreement") of up to $30 million with Aspire Capital Fund, LLC ("Aspire Capital

SALT LAKE CITY, Feb. 27, 2020 /PRNewswire/ -- Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced interim blinded data from the VISIONARY-MS Phase 2 study demonstrating median improvements in functional scores in the enrolled population of patients with relapsing multiple sclerosis (MS). The interim results will be featured in

SAN DIEGO, Feb. 27, 2020 /PRNewswire/ -- IQ4I Research & Consultancy published a new report on "Medical Device Contract Manufacturing (MDCM) Global Market – Forecast To 2026."

ST. LOUIS, Feb. 27, 2020 /PRNewswire/ -- There's a good chance that a patient of Mercy's Dr. Charles Albritton, a Leap Day baby and an OB-GYN, could end up having a baby this Leap Day, Feb. 29. Because the special day occurs only every four years, a Leap Day birthday is a rarity. Of more than 45,000 employees, Dr. Albritton and 33 others are M

ATLANTA, Feb. 27, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), brings to the attention of its shareholders a Letter to Stakeholders and Investor

FLOWER MOUND, Texas, Feb. 27, 2020 /PRNewswire/ -- The CBD gummies from cbdMD have been named the best CBD gummies of the year by CBDOilUsers.com, a leading CBD consumer education website. Th

HOUSTON, Feb. 27, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced the Company's Chief Executive Officer John Climaco w